Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
about
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress DisordersDiagnosis and Treatment of Agoraphobia with Panic DisorderThree year naturalistic outcome study of panic disorder patients treated with paroxetineCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersThe effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorderThe efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating ScalesSex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies.A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study.Sertraline in the treatment of anxiety disorders.The neurobiology of anxiety disorders: implications for psychiatric nursing practice.Time to response in panic disorder in a naturalistic setting: combination therapy with alprazolam orally disintegrating tablets and serotonin reuptake inhibitors compared to serotonin reuptake inhibitors alone.Management of anxiety disorders: the added challenge of comorbidity.Anxiety and Depression: Optimizing Treatments.Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.Serotonergic drugs in the treatment of depressive and anxiety disorders.Pharmacotherapy of anxious disorders.Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.Mistreating Psychology in the Decades of the BrainDosing of Selective Serotonin Reuptake InhibitorsPanic Disorder and Chest Pain: Mechanisms, Morbidity, and Management.Treatment-resistant panic disorder.Paroxetine: a review of its pharmacology, pharmacokinetics and utility in the treatment of a variety of psychiatric disorders.Moving Psychopathology Forward.Long-term Escitalopram Treatment in Korean Patients with Panic Disorder: A Prospective, Naturalistic, Open-label, Multicenter Trial.Serotonin modulates anxiety-like behaviors during withdrawal from adolescent anabolic-androgenic steroid exposure in Syrian hamstersPharmacotherapy of panic disorder.INFLUENCE OF STUDY DESIGN ON TREATMENT RESPONSE IN ANXIETY DISORDER CLINICAL TRIALSVenlafaxine in the treatment of panic disorderAnxiety disorders: a comprehensive review of pharmacotherapies.A pharmacological approach to panic disorder during pregnancy.A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary Care.Psychiatric diagnosis and clinical trial completion rates: analysis of the FDA SBA reports.Self-rated importance of religion predicts one-year outcome of patients with panic disorder.Initiation of illusions after combination of zolpidem and paroxetine in a young woman: a case report.SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis.Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia.Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients.History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.
P2860
Q22305681-83D2522C-9190-48D2-A1EC-7792F8B6FE54Q22305826-C2857918-C078-41B0-AAF3-C029D5F562B7Q24797730-7C06FCA1-B97A-4762-8737-5073312C03A1Q27009995-503EE292-2963-408B-B81D-E9921CCCA8EBQ28296985-34C9C834-8170-434F-A08D-78175320999CQ28542596-CA234DCD-E49D-4E82-B029-59A47B004CD9Q30438702-B5E117FB-934E-4F90-AB42-953FD452B48DQ33452892-5D1A6242-D2F8-4CAF-965B-6853FE5B03B4Q33914087-D484CB78-62CD-48AC-9CA9-0E1852693649Q33934637-CB3FA6CE-0FB4-4F36-9F47-9EE39BD655ECQ34156583-5134E6FE-A0CD-418D-9F34-A7539F5869ABQ34218830-AFA7854E-41C1-4AA6-807C-3435E8C35289Q34304950-EADC8D80-9F2A-4C46-B724-6BF1408197C6Q34369492-7838B3A7-FB57-4C00-BFF3-26B0F53BB200Q34465555-A8B0FBD3-6672-48BB-9BA6-FBEA0E80531DQ34865036-07F1353C-A562-45E4-A186-3F92DCEDA0DFQ34982492-5FC8C962-4242-471E-AA61-E2D1098B86B3Q35011794-77B6D3DC-615C-4770-8EA3-A5EFD5778134Q35097518-ACAF59CE-C812-46E3-903B-C5E7AB30326CQ35224964-706FE474-CA04-46A8-96FD-8221C17B465FQ35666956-4E872B1A-3E39-45C6-BC28-905DDD7C3BF2Q35667037-71157739-E618-46BF-958D-495DAB8861D9Q35901886-E79746C4-EF81-499D-BDF8-FB6A9F554DDFQ36181295-8A6E8196-DBEC-456B-BEE1-E9E4051D1F3EQ36551926-B62648AB-B393-4AE2-BE41-8290F3FA7243Q36600821-3D0DE557-4D70-45A9-9E4A-9EDD4E14D120Q36729284-4294D954-30F3-455C-BAA0-D636BA0ECCB9Q36876452-64A22041-EF19-4761-B6BA-B621A4DD90E1Q37041164-0A47072B-DF38-4A17-BACA-BAAD2CA5B27FQ37125514-AC9D6CD6-1FDA-428F-8564-D03B6DB09BDCQ37244064-5CB701F0-D3F7-4DA6-B852-295304740E24Q38516009-12F481B8-B93D-40E8-93E5-B7582322EE02Q39853665-A4216A55-CCB8-4FD5-B713-9C2E173D27D1Q40240452-C124DBE3-6060-4DEA-8CD6-1F0906F4AF59Q40326275-7F435CD9-5B29-4AA8-96C8-2C96513AA8D1Q42348726-2417C859-23F6-4AAD-AAA5-1649A588E68CQ44115958-C571AD52-9210-4FA1-929A-F66278F292DAQ44667926-33694257-75CC-4965-90AD-85E6ADEA04D6Q45009930-CBA33C19-204B-422F-9F69-1ADBD53FC696Q46042995-7C14A68A-45FF-4EF9-A800-C3F407DD1B99
P2860
Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Double-blind, fixed-dose, plac ...... e treatment of panic disorder.
@ast
Double-blind, fixed-dose, plac ...... e treatment of panic disorder.
@en
Double-blind, fixed-dose, plac ...... e treatment of panic disorder.
@nl
type
label
Double-blind, fixed-dose, plac ...... e treatment of panic disorder.
@ast
Double-blind, fixed-dose, plac ...... e treatment of panic disorder.
@en
Double-blind, fixed-dose, plac ...... e treatment of panic disorder.
@nl
prefLabel
Double-blind, fixed-dose, plac ...... e treatment of panic disorder.
@ast
Double-blind, fixed-dose, plac ...... e treatment of panic disorder.
@en
Double-blind, fixed-dose, plac ...... e treatment of panic disorder.
@nl
P2093
P356
P1476
Double-blind, fixed-dose, plac ...... e treatment of panic disorder.
@en
P2093
Ballenger JC
Bushnell W
Wheadon DE
P356
10.1176/AJP.155.1.36
P407
P577
1998-01-01T00:00:00Z